CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended	6 Months Ended		12 Months Ended
	Oct. 01, 2016	Oct. 01, 2016	Sep. 26, 2015	Oct. 01, 2016
Cash Flows from Operating Activities:
Net Earnings (Loss)	$ 6,144,000	$ 6,082,000	$ 9,490,000	$ 51,050,000
Adjustments to Reconcile Net (Loss) Earnings to Net Cash Used in Operations:
Depreciation & Amortization		12,018,000	10,487,000
Gain on the Sale of Assets		48,000	(143,000)
Deferred Income Tax Expense (Benefit)		(2,467,000)	(2,183,000)
Impairment Provision		1,462,000	(66,000)
Earnings From Equity Investment	270,000	(167,000)	86,000
Changes in Operating Assets and Liabilities (Net of Acquisition):
Accounts Receivable		(25,939,000)	(13,459,000)
Inventories		(204,289,000)	(289,291,000)
Other Current Assets		608,000	14,448,000
Income Taxes		1,198,000	2,099,000
Accounts Payable, Accrued Expenses and Other Liabilities		183,025,000	211,664,000
Net Cash Used in Operations		(28,421,000)	(56,868,000)
Cash Flows from Investing Activities:
Additions to Property, Plant and Equipment		(14,518,000)	(3,111,000)
Proceeds from the Sale of Assets		13,000	155,000
Purchase Equity Method Investment			0
Net Cash Used in Investing Activities		(14,505,000)	(2,956,000)
Cash Flow from Financing Activities:
Long-Term Borrowing		183,744,000	154,763,000
Payments on Long-Term Debt		(136,613,000)	(84,525,000)
Payments on Notes Payable		(402,000)	(9,903,000)
Other		(1,248,000)	(74,000)
Purchase of Treasury Stock		(1,021,000)	(1,636,000)
Dividends		(12,000)	(12,000)
Net Cash Provided by Financing Activities		44,448,000	58,613,000
Net Increase in Cash and Cash Equivalents		1,522,000	(1,211,000)
Cash and Cash Equivalents, Beginning of the Period		8,602,000	10,608,000	9,397,000
Cash and Cash Equivalents, End of the Period	10,124,000	10,124,000	$ 9,397,000	10,124,000
Noncash Transactions [Abstract]
Property, Plant and Equipment Issued Under Capital Lease	$ 15,416,000	$ 15,416,000		$ 15,416,000